Transrectal ultrasound-guided punch biopsies of the prostate. Indication, technique, results, and complications;Ultraschallgesteuerte transrektale prostatastanzbiopsien: Indikation, technik, ergebnisse und komplikationen

Urologe - Ausgabe A

Volumn 42, Issue 9, 2003, Pages 1188-1195

  Palisaar, J ^b   Eggert, T ^a   Graefen, M ^b   Haese, A ^b   Huland, H ^b  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^b NONE

Author keywords

Cancer detection; Complication; Indication; Punch biopsy; Re biopsy; TRUS

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; ADVANCED CANCER; AGED; CANCER SIZE; DIAGNOSTIC ACCURACY; DIAGNOSTIC PROCEDURE; HUMAN; MALE; PROSTATE CANCER; PROSTATE CARCINOMA; PUNCH BIOPSY; REVIEW; SENSITIVITY AND SPECIFICITY; TRANSRECTAL ULTRASONOGRAPHY; CANCER STAGING; ECHOGRAPHY; ENDOSCOPIC ECHOGRAPHY; METHODOLOGY; MIDDLE AGED; NEEDLE BIOPSY; PATHOLOGY; PREDICTION AND FORECASTING; PROSTATE; PROSTATE TUMOR;

ADULT; AGED; BIOPSY, NEEDLE; ENDOSONOGRAPHY; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; PREDICTIVE VALUE OF TESTS; PROSTATE; PROSTATIC NEOPLASMS; ULTRASONOGRAPHY, INTERVENTIONAL;

EID: 1542652128     PISSN: 03402592     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00120-003-0422-4     Document Type: Review

References (58)

1. Keetch DW, Catalona WJ, Smith DS (1994) Serial prostate biopsies in men with persistently elevated serum prostate specific antigen values. J Urol 151: 571
2. Hodge KK, McNeal JE, Terris MK, Stamey TA (1989) Random systematic versus directed ultrasound guided transrectal core biopsies of the prostate. J Urol 142: 71-75
3. Stamey TA (1995) Making the most out of six systematic sextant biopsies. Urology 45: 2-12
4. Keetch DW, Catalona WJ, Smith DS (1994) Serial prostatic biopsies in men with persistently elevated serum prostate specific antigen values. J Urol 151: 1571-1574
5. Ellis WJ, Brawer MK (1995) Repeat prostate needle biopsy: who needs it? J Urol 153: 1496-1498
6. Graefen M, Haese A, Pichlmeier U et al. (2001) A validated strategy for side specific prediction of organ confined prostate cancer: a tool to select for nerve sparing radical prostatectomy. J Urol 165:857-863
7. Albertsen PC, Hanley JA, Gleason DF, Barry MJ (1998) Competing risk analysis of men aged 55 to 74 years at diagnosis managed conservatively for clinically localized prostate cancer. JAMA 16: 975-980
8. Schröder FH, van der Maas P, Beemsterboer P (1998) Evaluation of the digital rectal examination as a screening test for prostate cancer. Rotterdam section of the European randomized study of screening for prostate cancer. J Natl Cancer Inst 90: 1817
9. Carvahal GF, Smith DS, Mager DE, Ramos C, Catalona WJ, (1999) Digital rectal examination for detecting prostate cancer at prostate specific antigen levels of 4 ng/ml or less. J Urol 161: 835
10. Catalona W J, Richie JP, Ahmann FR et al. (1994) Comparison of digital rectal examination and serum prostate specific antigen in early detection of prostate cancer: Results of a multicenter clinical trial of 6630 men. J Urol 151: 1283-1290
11. Catalona WJ, Hudson MA, Scardino PT et al. (1994) Selection of optimal prostate specific antigen cutoffs for early detection of prostate cancer: receiver operating characteristic curves. J Urol 152: 2037-2042
12. Cooner WH, Mosley BR, Rutherford CL Jr et al. (1990) Prostate cancer detection in a clinical urological practice by ultrasonography, digital rectal examination and prostate specific antigen. J Urol 143: 1146
13. Ellis WJ, Chetner MP, Preston SD, Brawer MK (1994) Diagnosis of prostatic carcinoma: The yield of serum prostate specific antigen, digital rectal examination and transrectal ultrasonography. J Urol 52: 1520
14. Gann PH, Hennekens CH, Stampfer MJ (1995) A prospective evaluation of plasma prostate-specific antigen for detection of prostatic cancer. JAMA 273: 289-294
15. Stamey AT (2001) Preoperative serum prostate-specific antigen (PSA) below 10 ng/ml predicts neither the presence of prostate cancer nor the rate of postoperative psa failure. Clin Chem 47: 631-634
16. Catalona WJ, Partin AW, Slawin KM et al. (1998) Use of the percentage of free prostate-specific antigen to enhance differentiation of prostate cancer from benign prostatic disease: a prospective multicenter clinical trial. JAMA 20: 1542-1547
17. Catalona WJ, Richie JP, Ahmann FR et al. (1994) Comparison of digital rectal examination and serum prostate specific antigen in the early detection of prostate cancer: results of a multicenter clinical trial of 6,630 men. J Urol 151: 1283-1290
18. Catalona WJ, Beiser JA, Smith DS (1997) Serum free prostate specific antigen and prostate specific antigen density measurements for predicting cancer in men with prior negative prostatic biopsies. J Urol 158: 2162-2167
19. Catalona WJ, Richie JP, Ahmann FR (1994) Comparison of digital rectal examination and serum prostate-specific antigen in the early detection of prostate cancer: Results of a multicenter clinical trial of 6,630 men. J Urol 151: 1283-1290
20. Catalona WJ, Partin AW, Slawin KM et al. (1998) Use of the percentage of free prostate-specific antigen to enhance differentiation of prostate cancer from benign prostatic disease: a prospective multicenter clinical trial. JAMA 279: 1542-1547
21. Oesterling JE, Jacobsen SJ, Chute CG, Guess HA, Girman CJ, Panser LA (1993) Serum prostate-specific antigen in a community-based population of healthy men. Establishment of age specific reference ranges. JAMA 270: 860
22. Carter HB, Pearson JD, Metter EJ, Brant LI,Chan DW, Andres R, Fozard JL, Walsh PC (1992) Longitudinal evaluation of prostate-specific antigen levels in men with and without prostate disease. JAMA 267: 2215-2220
23. Smith DS, Catalona WJ (1994) Rate of change in serum prostate specific antigen levels as a method for prostate cancer detection. J Urol 152: 1163-1167
24. Brawer MK, Aramburu EA, Chen GL, Preston SD, Ellis WJ. The inability of prostate specific antigen index to enhance the predictive the value of prostate specific antigen in the diagnosis of prostatic carcinoma. J Urol 150: 369-373
25. Hodge KK, McNeal JE, Terris MK, Stamey TA (1989) Random systematic versus directed ultrasound guided transrectal core biopsies of the prostate. J Urol 142: 71-75
26. Norberg M, Egevad L, Holmberg L, Sparen P, Norlen BJ, Busch C (1997) The sextant protocol for ultrasound-guided core biopsies of the prostate underestimates the presence of cancer. Urology 50: 562-566
27. Presti JC Jr, Chang JJ, Bhargava V, Shinohara K (2000) The optimal systematic prostate biopsy scheme should include 8 rather than 6 biopsies: results of a prospective clinical trial. J Urol 163: 163-167
28. Babaian RJ, Toi A, Kamoi K, Troncoso P, Sweet J, Evans R, Johnston D, Chen M (2000) A comparative analysis of sextant and an extended 11-core multisite directed biopsy strategy. J Urol 163: 152-157
29. Gore JL, Shariat SF, Miles BJ, Kadmon D, Jiang N, WheelerTM, Slawin KM. Optimal combinations of systematic sextant and laterally directed biopsies for the detection of prostate cancer. J Urol 165: 1554-1559
30. Naughton CK, Miller DC, Mager DE, Ornstein DK, Catalona WJ (2000) A prospective randomized trial comparing 6 versus 12 prostate biopsy cores: impact on cancer detection. J Urol 164: 388-392
31. Eskew LA, Bare RL, McCullough DL (1997) Systematic 5 region prostate biopsy is superior to sextant method for diagnosing carcinoma of the prostate. J Urol 157: 199-203
32. Djavan B, Remzi M, Marberger M (2003) When to biopsy and when to stop biopsying. Urol Clin North Am 30: 252-262
33. Uzzo RG, Wei JT, Waldbaum RS, Perlmutter AP, Byrne JC, Vaughan ED Jr (1995) The influence of prostate size on cancer detection. Urology. 46: 831-836
34. Karakiewicz PI, Hanley JA, Bazinet M (1998) Three-dimensional computer-assisted analysis of sector biopsy of the prostate. Urology 52: 208-212
35. San Francisco IF, DeWolf WC, Rosen S, Upton M, Olumi AF (2003) Extended prostate needle biopsy improves concordance of Gleason grading between prostate needle biopsy and radical prostatectomy. J Urol 169: 136-140
36. Lui PD, Terris MK, McNeal JE, Stamey TA (1995) Indications for ultrasound guided transition zone biopsies in the detection of prostate cancer. J Urol 153: 1000-1003
37. Fleshner NE, Fair WR (1997) Indications for transition zone biopsy in the detection of prostatic carcinoma. J Urol 157: 556-558
38. Terris MK, Pham TQ, Issa MM, Kabalin JN (1997) Routine transition zone and seminal vesicle biopsies in all patients undergoing transrectal ultrasound guided prostate biopsies are not indicated. J Urol 157: 204-206
39. Bazinet M, Karakiewicz PI, Aprikian AG et al. (1996) Value of systematic transition zone biopsies in the early detection of prostate cancer. J Urol 155: 605-606
40. Epstein JI, Walsh PC, Sauvageot J, Carter HB (1997) Use of repeat sextant and transition zone biopsies for assessing extent of prostate cancer. Urol 58: 1886-1890
41. Lui PD, Terris MK, McNeal JE, Stamey TA (1995) Indications for ultrasound guided transition zone biopsies in the detection of prostate cancer. J Urol 153: 1000-1003
42. Keetch DW, Catalona WJ (1995) Prostatic transition zone biopsies in men with previous negative biopsies and persistently elevated serum prostate specific antigen values. J Urol 154: 1795-1797
43. Djavan B, Remzi M, Schulman CC, Marberger M, Zlotta AR (2002) Repeat prostate biopsy: who, how and when? A review. Eur Urol 42: 93-103
44. Djavan B, Zlotta A, Remzi M, Ghawidel K, Basharkhah A, Schulman CC, Marberger M (2000) Optimal predictors of prostate cancer on repeat prostate biopsy: a prospective study of 1,051 men. J Urol 163: 1144-1148
45. Djavan B, Mazal P, Zlotta A (2001) Pathological features of prostate cancer detected on initial and repeat prostate biopsy: results of the prospective European Prostate Cancer Detection study. Prostate 47: 111-117
46. Stewart CS, Leibovich BC, Weaver AL, Lieber MM (2001) Prostate cancer diagnosis using a saturation needle biopsy technique after previous negative sextant biopsies. J Urol 166: 86-91
47. Park S, Shinohara K, Grossfeld GD, Carroll PR (2001) Prostate cancer detection in men with prior high grade prostaticintraepithelial neoplasia or atypical prostate biopsy. J Urol 165: 1409-1414
48. Davidson D, Bostwick DG, Qian Jet al. (1995) Prostatic intraepithelial neoplasia is a risk factor for adenocarcinoma: predictive accuracy in needle biopsies. J Urol 154: 1295-1299
49. Raviv G, Zlotta AR, Janssen T, Descamps F, Vanegas JP, Verhest A, Schulman CC (1996) Do prostate specific antigen and prostate specific antigen density enhance the detection of prostate carcinoma after initial diagnosis of prostatic intraepithelial neoplasia without concurrent carcinoma? Cancer 77: 2103-2108
50. Raviv G, Zlotta AR, Jannssen TH et al. (1996) Does prostate specific antigen and prostate specific antigen density enhance the detection of prostate cancer in patients initially diagnosed to have prostatic intraepithelial neoplasia? Cancer 77: 2103-2108
51. Zlotta AR, Raviv G, Schulman CC (1996) Clinical prognostic criteria for later diagnosis of prostate carcinoma in patients with initial isolated prostatic intraepithelial neoplasia. Eur Urol 30: 249-255
52. Epstein JI, Grignon DJ, Humphrey PA, McNeal JE, Sesterhenn IA, Troncoso P, Wheeler TM (1995) Interobserver reproducibility in the diagnosis of prostatic intraepithelial neoplasia. Am J Surg Pathol 19: 873-886
53. Brawer MK, Bigler SA, Sohlberg OE, Nagle RB, Lange PH (1991) Significance of prostatic intraepithelial neoplasia on prostate needle biopsy. Urology 38: 103-107
54. Keetch DW, Humphrey P, Stahl D, Smith DS, Catalona WJ (1995) Morphometric analysis and clinical followup of isolated prostatic intraepithelial neoplasia in needle biopsy of the prostate. J Urol 154: 347-351
55. Naughton CK, Ornstein DK, Smith DS, Catalona WJ (2000) Pain and morbidity of transrectal ultrasound guided prostate biopsy: a prospective randomized trial of 6 versus 12 cores. J Urol 163: 168-171
56. Djavan B, Waldert M, Zlotta A et al. (2001) Safety and morbidity of first and repeat transrectal ultrasound guided prostate needle biopsies: results of a prospective European prostate cancer detection study. J Urol 166: 856-860
57. Eskew LA, Woodruff RD, Bare RL, McCullough DL (1998) Prostate cancer diagnosed by the 5 region biopsy method is significant disease. J Urol 160: 794-796
58. Chan TY, Chan DY, Stutzman KL, Epstein JI (2001) Does increased needle biopsy sampling of the prostate detect a higher number of potentially insignificant tumors? J Urol 166: 2181-2184